Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery.
about
Latest medical treatment strategies for venous thromboembolism.Forecasting drug utilization and expenditure in a metropolitan health region.Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery.Simplifying thromboprophylaxis could improve outcomes in orthopaedic surgery.Lower limb contrast venography: a modified technique for use in thromboprophylaxis clinical trials for the accurate evaluation of deep vein thrombosis.The effect of anticoagulant pharmacotherapy on fracture healing.Safety, pharmacokinetics and pharmacodynamics of single/multiple doses of the oral, direct Factor Xa inhibitor rivaroxaban in healthy Chinese subjects.Dabigatran etexilate for the prophylaxis of venous thromboembolism after hip or knee replacement rationale for dose regimen.Developments in factor Xa inhibitors for the treatment of thromboembolic disorders.Investigational factor Xa inhibitors for thrombosis and acute coronary syndromes.Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban.Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study.Development of oral anticoagulants.Prevention and treatment of venous thromboembolism with new oral anticoagulants: a practical update for clinicians.3-(3-Chloro-anilino)-1-(3,5-dimethyl-1H-pyrazol-1-yl)propan-1-one.A novel prothrombin time assay for assessing the anticoagulant activity of oral factor Xa inhibitors.Venous thromboembolism prophylaxis after total knee or hip replacement: treatment pattern and outcomes.Characterization of total plasma glycosaminoglycan levels in healthy volunteers following oral administration of a novel antithrombotic odiparcil with aspirin or enoxaparin.The Diagnosis and Management of Early Deep Vein Thrombosis.Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial.
P2860
Q33375535-9B51F789-22B1-4399-A432-EA0B793684FEQ33579584-D0BF65F9-BA32-4EE8-84BA-6866B6C343F3Q34635335-154BCBE7-A0CB-4F64-98D1-236AA6FE508BQ35536242-DBB81B97-80F5-4BF5-A143-E2A2B552D32CQ36957164-3E199CB6-9D6A-44A3-B701-23A3EE87CA81Q37142069-87BFBE1D-8757-42E9-BF8C-6F28F44B5F16Q37321425-78174DC6-1C27-4373-BBDE-5579B7E3CBA2Q37583245-3B4D7747-73EE-43CC-8CB8-B40E21977DCFQ37646551-66A3299E-43EF-40CC-83E4-EE2F93A1F57DQ37850800-E0134B85-2167-460A-84C9-E8E00F451784Q37889269-7F51AA38-B00C-4EED-922D-1DC4B6733946Q38393247-E705D463-BE2F-4985-8B50-E4095D593383Q41121751-7619BBC9-65D9-4310-96C4-D23593C4180EQ41205933-E213361F-42C8-4CFF-96A7-D26DFC950D87Q42387749-061963E8-B2EF-4140-902E-1261132D780DQ44465978-F4694D2F-BE90-447D-A8F5-3AF167C1F8D3Q44608505-718A28A7-2F1A-4176-8004-9BBD26E785A7Q46403531-920FB610-18CD-4A2C-BB31-362B433B4D07Q51496808-EB64C3FB-B2CF-488E-A714-645247063E18Q55044458-5B258535-EAD2-44F7-A79C-451DCA2769A5
P2860
Oral anticoagulants in development: focus on thromboprophylaxis in patients undergoing orthopaedic surgery.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Oral anticoagulants in develop ...... ndergoing orthopaedic surgery.
@ast
Oral anticoagulants in develop ...... ndergoing orthopaedic surgery.
@en
type
label
Oral anticoagulants in develop ...... ndergoing orthopaedic surgery.
@ast
Oral anticoagulants in develop ...... ndergoing orthopaedic surgery.
@en
prefLabel
Oral anticoagulants in develop ...... ndergoing orthopaedic surgery.
@ast
Oral anticoagulants in develop ...... ndergoing orthopaedic surgery.
@en
P1433
P1476
Oral anticoagulants in develop ...... ndergoing orthopaedic surgery.
@en
P2093
Bengt I Eriksson
Daniel J Quinlan
P2860
P304
P356
10.2165/00003495-200666110-00001
P577
2006-01-01T00:00:00Z
P5875
P6179
1013294833